Mobia Medical, Inc.·3

Jun 29, 7:48 PM ET

GPG JCT, LLC 3

3 · Mobia Medical, Inc. · Filed Jun 29, 2026

Insider Transaction Report

Form 3
Period: 2026-05-07
Holdings
  • Series D Preferred Stock

    [F1][F2][F10]
    (indirect: See Footnote)
    Common Stock (18,374 underlying)
  • Series E-1 Preferred Stock

    [F1][F2][F10]
    (indirect: See Footnote)
    Common Stock (116,940 underlying)
  • Series E-2 Preferred Stock

    [F1][F2][F10]
    (indirect: See Footnote)
    Common Stock (56,421 underlying)
  • Convertible Notes

    [F3][F2][F10]
    (indirect: See Footnote)
    Common Stock (41,666 underlying)
  • Series E-2 Preferred Stock

    [F1][F4][F10]
    (indirect: See Footnote)
    Common Stock (477,329 underlying)
  • Series F Preferred Stock

    [F1][F4][F10]
    (indirect: See Footnote)
    Common Stock (45,711 underlying)
  • Convertible Notes

    [F3][F4][F10]
    (indirect: See Footnote)
    Common Stock (32,750 underlying)
  • Series F Preferred Stock

    [F1][F5][F10]
    (indirect: See Footnote)
    Common Stock (282,122 underlying)
  • Series D Preferred Stock

    [F1][F6][F10]
    (indirect: See Footnote)
    Common Stock (60,579 underlying)
  • Series D Preferred Warrant (right to buy)

    [F7][F6][F10]
    (indirect: See Footnote)
    Common Stock (9,474 underlying)
  • Series E-1 Preferred Stock

    [F1][F8][F10]
    (indirect: See Footnote)
    Common Stock (24,506 underlying)
  • Series D Preferred Stock

    [F1][F9][F10]
    (indirect: See Footnote)
    Common Stock (43,640 underlying)
  • Series D Preferred Warrant (right to buy)

    [F7][F9][F10]
    (indirect: See Footnote)
    Common Stock (6,890 underlying)
Footnotes (10)
  • [F1]Each share of Series D Preferred Stock, Series F Preferred Stock, Series E-1 Preferred Stock and Series E-2 Preferred Stock will convert into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.
  • [F10]Green Park & Golf Ventures II, LLC ("GPG Ventures II") is the managing member of each of JCT, MTI 22, MTI 25, MTI 3-17, PHL, and RM. Clay M. Heighten, MD, Carl D. Soderstrom and Gilbert G. Garcia II are managers of GPG Ventures II and share voting and dispositive power with respect to the shares held by each of JCT, MTI 22, MTI 25, MTI 3-17, PHL, and RM., and as a result may be deemed to beneficially own such securities.
  • [F2]The securities are held by GPG JCT, LLC ("JCT").
  • [F3]The Convertible Notes will automatically convert into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.
  • [F4]The securities are held by GPG MTI 22, LLC ("MTI 22").
  • [F5]The securities are held by GPG MTI 25, LLC ("MTI 25").
  • [F6]The securities are held by GPG MTI 3-17 Investment, LLC ("MTI 3-17").
  • [F7]Common stock is issuable upon exercise of warrant to purchase the Series D Preferred Stock. The warrants are currently exercisable and have an exercise price of $4.207 per share. Unless exercised earlier, the warrants will expire on May 25, 2033.
  • [F8]The securities are held by GPG PHL, LLC ("PHL").
  • [F9]The securities are held by GPG RM Investment, LLC ("RM").

Documents

1 file
  • 3
    ownership.xmlPrimary

    3